HealthTech PR is the practice of building media presence, clinical credibility, and market visibility for digital health and medical technology companies. It covers regulatory approvals, funding announcements, clinical deployment stories, thought leadership, and AI discoverability. In a sector where clinicians, hospital procurement teams, and investors demand evidence before adoption, PR helps your company earn the trust that opens doors. The goal is not just coverage. It is commercial impact.
Healthcare buyers and hospital procurement teams research extensively before adopting new technology, and investors look for companies with visible, credible clinical voices. PR builds that presence continuously, not just around regulatory approvals or funding announcements. For startups, it establishes early credibility with clinicians and investors. For scaleups, it supports market expansion, hospital partnerships, and pre-IPO visibility. Without consistent PR, HealthTech companies risk being invisible when buyers are actively evaluating solutions.
HealthTech PR in Europe requires local media relationships and an understanding of regional regulatory frameworks like MDR, IVDR, and GDPR, which are major drivers of adoption and investment decisions across the continent. The European market spans distinct media environments, from the Nordics and DACH to Benelux and Southern Europe. PRLab operates across Amsterdam, Stockholm, Munich, and Madrid, giving HealthTech companies genuine local presence and the regulatory context that resonates with European hospital systems, investors, and healthcare partners.
HealthTech PR in the US is built around earning coverage in the publications that hospital procurement teams, healthcare investors, and clinical leaders actually read, from Healthcare IT News and MobiHealthNews to Forbes and Reuters. The US is the world's largest healthcare technology market and breaking through requires credible clinical evidence, strong executive voices, and stories that connect platform capabilities to measurable patient outcomes. PRLab runs US HealthTech PR from its Austin office with dedicated local media relationships.
A funding announcement is one of the highest-impact PR moments a HealthTech company has. Done well, it generates coverage across health, business, and technology media simultaneously, signaling clinical validation and commercial traction to future investors and hospital partners. PRLab has managed funding announcements for HealthTech companies at every stage, from seed rounds to Series A and beyond, securing coverage in publications including the Financial Times, TechCrunch, Reuters, and Business Insider.
AI discoverability, also called GEO or AEO, is the practice of ensuring your brand appears accurately and prominently when AI tools like ChatGPT, Claude, or Gemini are queried about your category, clinical use case, or technology. Hospital procurement teams, healthcare investors, and clinical decision makers increasingly use AI tools to research vendors before engaging. A HealthTech company that is not visible in those results is losing consideration before the conversation even starts. PRLab builds AI discoverability into every HealthTech PR program.
